[go: up one dir, main page]

IS8356A - Medications, methods and dose control for the treatment and prevention of acute coronary heart disease - Google Patents

Medications, methods and dose control for the treatment and prevention of acute coronary heart disease

Info

Publication number
IS8356A
IS8356A IS8356A IS8356A IS8356A IS 8356 A IS8356 A IS 8356A IS 8356 A IS8356 A IS 8356A IS 8356 A IS8356 A IS 8356A IS 8356 A IS8356 A IS 8356A
Authority
IS
Iceland
Prior art keywords
medications
prevention
treatment
methods
heart disease
Prior art date
Application number
IS8356A
Other languages
Icelandic (is)
Inventor
L. Bisgaier Charles
V. Rodrigueza Wendi
D. Lalwani Narendra
Hartman Daniel
Johansson Jan
Original Assignee
Esperion Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/034800 external-priority patent/WO2005041866A2/en
Application filed by Esperion Therapeutics, Inc. filed Critical Esperion Therapeutics, Inc.
Publication of IS8356A publication Critical patent/IS8356A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IS8356A 2003-10-20 2006-03-16 Medications, methods and dose control for the treatment and prevention of acute coronary heart disease IS8356A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51311603P 2003-10-20 2003-10-20
PCT/US2004/034800 WO2005041866A2 (en) 2003-10-20 2004-10-19 Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes

Publications (1)

Publication Number Publication Date
IS8356A true IS8356A (en) 2006-03-16

Family

ID=37444404

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8356A IS8356A (en) 2003-10-20 2006-03-16 Medications, methods and dose control for the treatment and prevention of acute coronary heart disease

Country Status (5)

Country Link
CN (1) CN1870894B (en)
AP (1) AP2006003578A0 (en)
IS (1) IS8356A (en)
TN (1) TNSN06114A1 (en)
ZA (1) ZA200602248B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013090978A1 (en) * 2011-12-21 2013-06-27 Csl Limited Dosage regime for apolipoprotein formulations
CN105483076B (en) 2015-12-23 2019-01-25 中国科学院生物物理研究所 A kind of preparation method of fat body and its application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603304D0 (en) * 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
WO2003026492A2 (en) * 2001-09-28 2003-04-03 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug

Also Published As

Publication number Publication date
AP2006003578A0 (en) 2006-04-30
CN1870894B (en) 2011-08-10
ZA200602248B (en) 2007-09-26
TNSN06114A1 (en) 2007-11-15
CN1870894A (en) 2006-11-29

Similar Documents

Publication Publication Date Title
BRPI0307673A2 (en) methods of treating vascular disease.
LT2878297T (en) MEDICINES FOR THE TREATMENT OR PREVENTION OF FIBROSIC DISEASES
CY2014028I1 (en) COMPOUNDS, PHARMACEUTICAL FORMS AND METHODS FOR THE TREATMENT OR PREVENTION OF ACNE ROSEPHUM
NO20053041D0 (en) Treatment of diabetes.
DE60308293D1 (en) Blood treatment catheter device
NO20052760D0 (en) Process for the treatment of cancer and related methods.
NO20053224D0 (en) Patient controlled drug administration device.
IS2722B (en) 1, 2, 3, 4- Tetrasetin indole for the treatment of respiratory diseases
EE200300212A (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic diseases
IS8142A (en) Medication useful for the treatment of pain
IS7814A (en) Phenethanolamine derivatives in the treatment of respiratory diseases.
NO20053150D0 (en) System for administering medicine.
LTC1562603I2 (en) New drugs for the treatment of chronic obstructive pulmonary diseases
NO20053817D0 (en) Preparations and Methods for Antiviral Combination Therapy.
DE60313805D1 (en) Controllable catheter
DE60322507D1 (en) CONTROLLABLE CATHETER OR THE LIKE
NO20052855D0 (en) Phosphonoxycinazoline derivatives and their pharmaceutical use.
IS8071A (en) Method for the treatment of nodular scoliosis, liposuction and related condition types and pharmaceutical compositions
EP1745808A4 (en) Medical filter material and, utilizing the same, extracorporeal circulation column and blood filter
DE602004008262D1 (en) DESIGNING IMPLANTABLE MEDICAL LINES
NO20050569D0 (en) Procedure for the treatment of severe heart failure and drug for this
EP1485109A4 (en) VASCULAR TREATMENT
EP1706129A4 (en) DRUG TREATMENT AGAINST COELIAC SPRUE
EP1500401A4 (en) Drugs for treating vascular diseases
ATE389742T1 (en) TISSUE TREATMENT PRODUCTS